Chapter 33 - Red Blood Cells Products
-
Add time:08/31/2019 Source:sciencedirect.com
Red blood cell (RBC) products are produced primarily from whole blood units but may also be collected by apheresis. RBC transfusions are indicated for the treatment of decreased oxygen-carrying capacity in the setting of anemia and decreased RBC mass. RBC products can be modified, such as by leukoreduction, irradiation, and washing, to meet the needs of patients. They are stored for up to 42 days at 1–6°C. During storage the cells undergo changes, termed the storage lesion, the clinical consequences of which are debatable.
We also recommend Trading Suppliers and Manufacturers of Red 33 (cas 1342-94-5). Pls Click Website Link as below: cas 1342-94-5 suppliers
Prev:Red 33 (cas 1342-94-5) dye co-encapsulated with cetyltrimethylammonium in mesoporous silica materials
Next:Chapter 33 - Red Sour Cherry for the Treatment of Diabetes Mellitus) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Identification of the IL-33 protein segment that controls subcellular localization, extracellular secretion, and functional maturation09/06/2019
- Biologics and immunotherapyIL-33trap is a novel IL-33–neutralizing biologic that inhibits allergic airway inflammation09/05/2019
- Interleukin-33 reduces neuronal damage and white matter injury via selective microglia M2 polarization after intracerebral hemorrhage in rats09/04/2019
- IL-33 contributes to disease severity in Psoriasis-like models of mouse09/03/2019
- Preparative separation and identification of novel subsidiary colors of the color additive D&C Red No. 33 (Acid Red 33 (cas 1342-94-5)) using spiral high-speed counter-current chromatography☆09/02/2019
- Chapter 33 - Red Sour Cherry for the Treatment of Diabetes Mellitus09/01/2019
- Red 33 (cas 1342-94-5) dye co-encapsulated with cetyltrimethylammonium in mesoporous silica materials08/30/2019
